{"references": ["Chan, J.F., To, K.K., Tse, H., Jin, D.Y., and Yuen, K.Y. (2013) Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 21, 544-555.", "Cui, J., Li, F. and Shi, Z.L. (2019) Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 17, 181-192.", "Hamming, I., Timens, W., Bulthuis, M.L.C., Lely, A.T., Navis, G.J. and Van Goor, H. (2004) Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus, A first step in understanding SARS pathogenesis. J Pathol. 203, 631-637.", "Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T. and Chen, Q. (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral. Sci. 12, 1-5.", "Plant, E.P., Sims, A.C., Baric, R.S., Dinman, J.D. and Taylor, D.R. (2013) Altering SARS coronavirus frameshift efficiency affects genomic and subgenomic RNA production. Viruses. 5, 279-294.", "Plant, E.P. and Dinman, J.D. (2008) The role of programmed-1 ribosomal frameshifting in coronavirus propagation. Front Biosci. 13, 4873- 4881.", "Guan, W.J., Ni, Z.Y., Hu, Y., Liang, W.H., Ou, C.Q., He, J.X., Liu, L., Shan, H., Lei, C.L., Hui, D.S.C., Du, B., Li, L.J., Zeng, G., Yuen, K.Y., Chen, R.C., Tang, C.L., Wang, T., Chen, P.Y., Xiang, J., Li, S.Y., Wang, J.L., Liang, Z.J., Peng, Y.X., Wei, L., Liu, Y., Hu, Y.H., Peng, P., Wang, J.M., Liu J.Y., Chen, Z., Li, G., Zheng, Z.J., Qiu, S.Q., Luo, J., Ye, C.J., Zhu, S.Y. and Zhong, N.S. (2020) Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708-1720.", "Ziebuhr, J. (2005) The Coronavirus Replicase. In: Coronavirus Replication and Reverse Genetics. Current Topics in Microbiology and Immunology. (L. Enjuanes), Springer, Berlin, 57-94.", "Lai, M.M., Baric, R.S., Makino, S., Keck, J.G., Egbert, J., Leibowitz, J.L. and Stohlman, S.A. (1985) Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol. 56, 449-456.", "Makino, S., Keck, J.G., Stohlman, S.A. and Lai, M.M. (1986) High-frequency RNA recombination of murine coronaviruses. J. Virol. 57, 729- 737.", "Kusters, J.G., Jager, E.J., Niesters, H.G and Van der Zeijst, B.A. (1990) Sequence evidence for RNA recombination in field isolates of avian coronavirus infectious bronchitis virus. Vaccine. 8, 605-608.", "Lee, C.W. and Jackwood, M.W. (2000) Evidence of genetic diversity generated by recombination among avian coronavirus IBV. Arch. Virol. 145, 2135-2148.", "Domingo, E. and Holland, J. (1997) RNA virus mutations and fitness for survival. Annu. Rev. Microbiol. 51, 151-178.", "Holmes, E.C. and Rambaut, A. (2004) Viral evolution and the emergence of SARS coronavirus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 359, 1059-1065", "Cherry, J.D. and Krogstad, P. (2004) SARS: the first pandemic of the 21st century. Pediatr. Res. 56, 1-5.", "Shu, Y. and McCauley, J. (2017) GISAID: Global initiative on sharing all influenza data \u2013 from vision to reality. EuroSurveillance. 22, (13), 30494.", "Burland, T.G. (2000) DNASTAR's Lasergene sequence analysis software. Methods Mol. Biol. 71-91.", "Needleman, S.B. and Wunsch, C.D. (1970) A general method applicable to the search for similarities in the amino acid sequence of two proteins. J. Mol. Biol. 48, 443-453.", "Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., Appel, R.D. and Bairoch, A. (2003) ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res. 31, 3784-3788.", "Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J. and Zhang, Y. (2015) The I-TASSER Suite: Protein structure and function prediction. Nat. Methods. 12, 7-8.", "Sch\u00fcttelkopf, A.W. and Van Aalten, D.M.F. (2004) PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D. 60, 1355-1363.", "Duhovny, D., Nussinov, R. and Wolfson, H.J. (2002) Efficient unbound docking of rigid molecules. In: Proceedings of the 2'nd Workshop on Algorithms in Bioinformatics (WABI) Lecture Notes in Computer Science. Rome, Italy. 185- 200.", "Schneidman-Duhovny, D., Inbar, Y., Polak, V., Shatsky, M., Halperin, I., Benyamini, H., Barzilai, A., Dror, O., Haspel, N., Nussinov, R. and Wolfson, H.J. (2003) Taking geometry to its edge: fast unbound rigid (and hinge-bent) docking. Proteins. 52, 107-112.", "Schneidman-Duhovny, D., Inbar, Y., Nussinov, R. and Wolfson, H.J. (2005) PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 33, W363-367.", "Mashiach, E., Schneidman-Duhovny, D., Peri, A., Shavit, Y., Nussinov, R. and Wolfson, H.J. (2010) An integrated suite of fast docking algorithms. Proteins. 78, 3197-3204.", "Trott, O. and Olson, A.J. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455-461.", "Grosdidier, A., Zoete, V. and Michielin, O. (2011) SwissDock, protein-small molecule docking web service based on EADock DSS. Nucleic Acids Res. 39 (suppl_2) W270\u2013W277", "Baysal, \u00d6. (2020) Figshare. Figure. Sequence comparison shows genomic differences of SARS-CoV-2 samples belonging to a) US, b) UK, c)Russia, d) Germany and e) China (reference genome from Wuhan) with Turkey. The analysis using Global Needleman Wunsch DNA fragment algorithm clearly shows genetic stability up to the first 6500 bp with alignment by using MAUVE. https://figshare.com/articles/figure/ Fig_1_png/12326345", "Tilocca, B., Soggiu, A., Sanguinetti M., Musella, V., Britti D., Bonizzi, L., Urbani, A. and Roncada, P. (2020) Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses. Microb. Infect. 22, 188-194.", "Zolfaghari Emameh, R., Nosrati, H. and Taheri, R.A. (2020) Combination of biodata mining and computational modelling in identification and characterization of ORF1ab polyprotein of SARS-CoV-2 isolated from Oronasopharynx of an Iranian patient. Biol. Proced Online. 22, 8.", "Woo, P.C., Huang, Y., Lau, S.K., Tsoi, H.W. and Yuen, K.Y. (2005) In silico analysis of ORF1ab in Coronavirus HKU1 genome reveals a unique putative cleavage site of Coronavirus HKU1 3C-like protease. Microbiol. Immunol. 49, 899-908.", "Chen, C.A. and Fang, J.M. (2013) Synthesis of oseltamivir and tamiphosphor from N-acetyl-D-glucosamine. Org Biomol Chem. 11, 7687- 7699.", "Lin, Y., Wu, C., Wang, X., Liu, S., Zhao, K., Kemper, T., Yu, H., Li, M., Zhang, J., Chen, M., Zhu, Y., Chen, X. and Lu, M. (2020) Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling. Autophagy. 16, 548-561.", "Koch, G. and Kant, A. (1990) Binding of antibodies that strongly neutralise infectious bronchitis virus is dependent on the glycosylation of the viral peplomer protein, in Coronaviruses and their Diseases. In: Advances in Experimental Medicine and Biology. (Cavanagh, D., Brown, T.D.K.), Springer, Boston, MA. 143-150.", "Maverakis, E., Kim, K., Shimoda, M., Gershwin, M.E., Patel, F., Wilken, R., Raychaudhuri, S., Ruhaak, L.R. and Lebrilla, C.B. (2015) Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review. J. Autoimmun. 57, 1-13.", "Pant, A., Cao, S. and Yang, Z. (2019) Asparagine is a critical limiting metabolite for Vaccinia virus protein synthesis during glutamine deprivation. J. Virol. 93, e01834-18", "Imperiali, B. and O'Connor, S.E. (1999) Effect of N-linked glycosylation on glycopeptide and glycoprotein structure. Curr. Opin. Chem. Biol. 3, 643-649.", "Jochmann, R., Thurau, M., Jung, S., Hofmann, C., Naschberger, E., Kremmer, E., Harrer, T., Miller, M., Schaft, N. and St\u00fcrzl, M. (2009) OLinked N-Acetylglucosaminylation of Sp1 inhibits the Human Immunodeficiency Virus Type 1 promoter. J. Virol. 83, 3704-3718.", "Han, D.P., Lohani, M. and Cho, M.W. (2007) Specific Asparagine-Linked glycosylation sites are critical for DC-SIGN- and L-SIGN-Mediated Severe Acute Respiratory Syndrome Coronavirus entry. J. Virol. 81, 12029-12039.", "Mondotte, J.A., Lozach, P.Y., Amara, A. and Gamarnik, A.V. (2007) Essential role of Dengue virus envelope protein N glycosylation at asparagine- 67 during viral propagation. J. Virol. 81, 7136-7148.", "Parodi, A.J. (2000) Protein glucosylation and its role in protein folding. Annu. Rev. Biochem. 69, 69-93.", "Van Etten, J.L., Gurnon, J.R., Yanai-Balser, G.M., Dunigan, D.D. and Graves, M.V. (2010) Chlorella viruses encode most, if not all, of the machinery to glycosylate their glycoproteins independent of the endoplasmic reticulum and Golgi. Biochim Biophys. Acta. 1800, 152-159.", "Knoops, K., Kikkert, M., Van den Worm, S.H.E, Zevenhoven-Dobbe, J.C., Van der Meer, Y., Koster, A.J., Mommaas, A.M. and Snijder, E.J. (2008) SARS-Coronavirus replication is supported by a reticulovesicular network of modified Endoplasmic Reticulum. PLoS Biol. 6. Article ID: e226.", "Piacente, F., Bernardi, C., Marin, M., Blanc, G., Abergel, C. and Tonetti, M.G. (2014) Characterization of a UDP-N-acetylglucosamine biosynthetic pathway encoded by the giant DNA virus Mimivirus. Glycobiology. 24, 51-61.", "Konopka, J.B. (2012) N-acetylglucosamine (GlcNAc) functions in cell signalling. Scientifica (Cairo). 2012, 489208.", "Kumaki, Y., Wandersee, M.K., Smith, A.J., Zhou, Y., Simmons, G., Nelson, N.M., Bailey, K.W., Vest, Z.G., Li, J.K.K., Chan, P.K.S., Smee, D.F. and Barnard, D.L. (2011) Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. Antivir. Res. 90, 22-32.", "Chou, C.F., Shen, S., Tan, Y.J., Fielding, B.C., Tan, T.H.P., Fu, J., Xu, Q., Lim, S.G. and Hong, W. (2005) A novel cell-based binding assay system reconstituting interaction between SARSCoV S protein and its cellular receptor. J. Virol. Methods. 123, 41-48.", "Gelb, L.D. and Lerner, A.M. (1965) Reovirus hemagglutination: inhibition by N-Acetyl-DGlucosamine. Science. 147, 404-405.", "Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 23, 3-25.", "Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin W. and Cheng, F. (2020a) Network-based drug repurposing for novel coronavirus 2019- nCoV/SARS-CoV-2. Cell. Discov. 6, 14.", "Leelananda, S.P. and Lindert, S. (2016) Computational methods in drug discovery. Beilstein J. Org. Chem. 12, 2694-2718.", "Li, G. and De Clercq, E. (2020) Therapeutic options for the 2019 novel coronavirus (2019- nCoV). Nat Rev Drug Discov. 19, 149-150.", "Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen H. and B. Cao. (2020b) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 395, P1054- 1062.", "Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., Li, X., Xia, J., Chen, N., Xiang, J., Yu, T., Bai, T., Xie, X., Zhang, L., Li, C., Yuan, Y., Chen, H., Li, H., Huang, H., Tu, S., Gong, F., Liu, Y., Wei, Y., Dong, C., Zhou, F., Gu, X., Xu, J., Liu, Z., Zhang, Y., Li, H., Shang, L., Wang, K., Li, K., Zhou, X., Dong, X., Qu, Z., Lu, S., Hu, X., Ruan, S., Luo, S., Wu, J., Peng, L., Cheng, F., Pan, L., Zou, J., Jia, C., Wang, J., Liu, X., Wang, S., Wu, X., Ge, Q., He, J., Zhan, H., Qiu, F., Guo, L., Huang, C., Jaki, T., Hayden, F.G., Horby, P.W., Zhang, D. and Wang, C. (2020) A trial of Lopinavir\u2013Ritonavir in adults hospitalized with severe Covid-19. N. Engl. J. Med. 382, 1787-1799."]}

The causative agent of the viral pneumonia outbreak in the world identified as SARS-CoV-2 leads to a severe respiratory illness like SARS and MERS. The pathogen spreading has turned into a pandemic dissemination and increased the mortality rate. Therefore, any useful information is essential for effective control of the disease. Our findings show the existence of unvarying sequence with no mutation in ORF1ab regions from 134 high-quality filtered genome sequences of SARS-CoV-2 downloaded from the GISAID database. We have detected this sequence region by using MAUVE analysis and pairwise alignment using Global Needleman Wunsch algorithm. All these results were also confirmed with the Clustal W analysis. The first 6500 bp of the consensus genome including ORF1ab region is an unvarying sequence in SARS-CoV-2 genome. Unvarying sequence in SARS-CoV-2 genome has been very similar to another spike protein, which belongs to feline infectious peritonitis virus strain UU4 (PDB 6JX7), depending on amino acid sequences encoded, and N-acetyl-D-glucosamine is the ligand of this protein according to the highest TM-score of predicted protein structure analysis. These results have confirmed that N-acetyl-D-glucosamine could play an important effect on pathogenicity of SARS-CoV-2. Also, our molecular docking analysis data supports a strong protein-ligand interaction of N-acetyl-D-glucosamine with spike receptor-binding domain bound with ACE2 (PDB 6M0J) and RNA-binding domain of nucleocapsid phosphoprotein (PDB 6WKP) from SARS-CoV-2. Therefore, binding of N-acetyl-D-glucosamine to these proteins could inhibit SARS-CoV-2’s replication. In the present work, we have suggested providing a repurposing compound for further in vitro and in vivo studies and new insights for ongoing clinical treatments as a new strategy to control of SARS-CoV-2 infections.